Correlation analysis of gene expression and clinical chemistry to identify biomarkers of skeletal myopathy in mice treated with PPAR agonist GW610742X

Biomarkers

Volumn 13, Issue 4, 2008, Pages 364-376

  Casey, W M ^a   Brodie, T ^b   Yoon, L ^a   Ni, H ^a   Jordan, H L ^a   Cariello, N F ^a  

^a GLAXOSMITHKLINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Biomarker; Correlation; Gene expression; Glycolysis; Myopathy; Oxidative stress; PPAR

Indexed keywords

ANKYRIN REPEAT DOMAIN 1; BIOLOGICAL MARKER; GENE PRODUCT; GW 610742X; METALLOTHIONEIN 1A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PROTEIN ANKRD1; PROTEIN MID1 INTERACTING PROTEIN 1; PROTEIN MID1IP1; PROTEIN MT1A; PROTEIN RRAD; RAS RELATED ASSOCIATED WITH DIABETES PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL EXPERIMENT; ARTICLE; CLINICAL CHEMISTRY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; CREATINE KINASE BLOOD LEVEL; FEMALE; GENE EXPRESSION REGULATION; GLYCOLYSIS; MALE; MYOPATHY; NONHUMAN; OXIDATIVE STRESS; TRANSLATION REGULATION;

ANIMALS; BIOLOGICAL MARKERS; CREATINE KINASE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; MALE; METALLOTHIONEIN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR DISEASES; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RAS PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REPRESSOR PROTEINS; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; THIAZOLES;

ANIMALIA; MUS; RATTUS;

EID: 45749124830     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500801903545     Document Type: Article

References (36)

1. Abel, J. and Ruiter, N. (1989) Inhibition of hydroxyl-radical-generated DNA degradation by metallothionein. Toxicology Letters, 47, pp. 191-196.
2. Anderson, S. P., Howroyd, P., Liu, J., Qian, X., Bahnemann, R., Swanson, C., Kwak, MK, Kensler, TW and Corton, JC. (2004) The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes. Journal of Biological Chemistry, 279, pp. 52390-52398.
3. Arany, I., Megyesi, JK, Nelkin, BD and Safirstein, RL. (2006) Kidney STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells. Kidney International, 70, pp. 669-674.
4. Bjorbaek, C., Elmquist, JK, Frantz, JD, Shoelson, SE and Flier, JS. (1998) Identification of SOCS-3 as a potential mediator of central leptin resistance. Molecular Cell, 1, pp. 619-625.
5. Bjorbaek, C., El-Haschimi, K., Frantz, JD and Flier, JS. (1999) The role of SOCS-3 in leptin signaling and leptin resistance. Journal of Biological Chemistry, 274, pp. 30059-30065.
6. Chen, C., Hennig, GE, Whiteley, HE, Corton, JC and Manautou, JE. (2000) Peroxisome proliferator-activated receptor alpha-null mice lack resistance to acetaminophen hepatotoxicity following clofibrate exposure. Toxicological Sciences, 57, pp. 338-344.
7. Desvergne, B., Michalik, L. and Wahli, W. (2006) Transcriptional regulation of metabolism. Physiological Review, 86, pp. 465-514.
8. Dhawan, D. and Goel, A. (1995) Further evidence for zinc as a hepatoprotective agent in rat liver toxicity. Experimental & Molecular Pathology, 63, pp. 110-117.
9. Emanuelli, B., Peraldi, P., Filloux, C., Chavey, C., Freidinger, K., Hilton, DJ, Hotamisligil, GS and Van Obberghen, EI. (2001) SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. Journal of Biological Chemistry, 276, pp. 47944-47949.
10. Farrell, GC. (2005) Signalling links in the liver: Knitting SOCS with fat and inflammation. Journal of Hepatology, 43, pp. 193-196.
11. Feige, JN, Gelman, L., Michalik, L., Desvergne, B. and Wahli, W. (2006) From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Progress in Lipid Research, 45, pp. 120-159.
12. Fernandez, V., Castillo, I., Tapia, G., Romanque, P., Uribe-Echevarria, S., Uribe, M., Cartier-Ugarte, D., Santander, G., Vial, MT and Videla, LA. (2007) Thyroid hormone preconditioning: Protection against ischemia-reperfusion liver injury in the rat. Hepatology, 45, pp. 170-177.
13. Guri, A., Hontecillas, R. and Bassaganya-Riera, J. (2006) Peroxisome proliferator-activated receptors: Bridging metabolic syndrome with molecular nutrition. Clinical Nutrition, 25, pp. 871-885.
14. Hodel, C. (2002) Myopathy and rhabdomyolysis with lipid-lowering drugs. Toxicology Letters, 128, pp. 159-168.
15. Ilany, J., Bilan, PJ, Kapur, S., Caldwell, JS, Patti, M-E, Marette, A. and Kahn, CR. (2006) Overexpression of Rad in muscle worsens diet-induced insulin resistance and glucose intolerance and lowers plasma triglyceride level. Proceedings of the National Academy of Science USA, 103, pp. 4481-4486.
16. Issemann, I. and Green, S. (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 347, pp. 645-650.
17. Jeyaseelan, R., Poizat, C., Baker, RK, Abdishoo, S., Isterabadi, LB, Lyons, GE and Kedes, L. (1997) A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. Journal of Biological Chemistry, 272, pp. 22800-22808.
18. Jiang, LJ, Maret, W. and Vallee, BL. (1998) The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitol dehydrogenase. Proceedings of the National Academy of Science USA, 95, pp. 3483-3488.
19. Kolbus, A., Blazquez-Domingo, M., Carotta, S., Bakker, W., Luedemann, S., von Lindern, M., Steinlein, P. and Beug, H. (2003) Cooperative signaling between cytokine receptors and the glucocorticoid receptor in the expansion of erythroid progenitors: Molecular analysis by expression profiling. Blood, 102, pp. 3136-3146.
20. Laville, M., Auboeuf, D., Khalfallah, Y., Vega, N., Riou, JP and Vidal, H. (1996) Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut 4 and lipoprotein lipase mRNA levels in human muscle. Journal of Clinical Investigation, 98, pp. 43-49.
21. Li, Y., Takemura, G., Okada, H., Miyata, S., Maruyama, R., Li, L., Higuchi, M., Minatoguchi, S., Fujiwara, T. and Fujiwara, H. (2006) Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovascular Research, 71, pp. 684-694.
22. Maret, W. (1994) Oxidative metal release from metallothionein via zinc-thiol/disulfide interchange. Proceedings of the National Academy of Science USA, 91, pp. 237-241.
23. Moller, DE, Bjorbaek, C. and Vidal-Puig, A. (1996) Candidate gene for insulin resistance. Diabetes Care, 19, pp. 396-400.
24. Moyers, JS, Bilan, PJ, Reynet, C. and Kahn, CR. (1996) Overexpression of Rad inhibits glucose uptake in cultured muscle and fat cells. Journal of Biological Chemistry, 271, pp. 23111-23116.
25. Peraza, MA, Burdick, AD, Marin, HE, Gonzalez, FJ and Peters, JM. (2006) The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicological Sciences, 90, pp. 269-295.
26. Powell, SR. (2000) The antioxidant properties of zinc. Journal of Nutrition, 130, pp. 1447S-1454S.
27. Qing, Y. and Stark, GR. (2004) Alternative activation of STAT1 and STAT3 in response to interferon-gamma. Journal of Biological Chemistry, 279, pp. 41679-41685.
28. Quesada, AR, Byrnes, RW, Krezoski, SO and Pettering, DH. (1996) Direct reaction of H2O2 with sulfhydryl groups in HL-60 cells: zinc-metallothionein and other sites. Archives of Biochemistry & Biophysics, 334, pp. 241-250.
29. Reynet, C. and Kahn, CR. (1993) Rad: A member of the Ras family overexpressed in muscle of type II diabetic humans. Science, 262, pp. 1441-1444.
30. Schafer, SC, Wallerath, T., Closs, EI, Schmidt, C., Schwartz, PM, Forstermann, U. and Lehr, HA. (2005) Dexamethasone suppresses eNOS and CAT-1 and induces oxidative stress in mouse resistance arterioles. American Journal of Physiology. Heart & Circulatory Physiology 2005, 288, pp. H436-H444.
31. Senn, JJ, Klover, PJ, Nowak, IA, Zimmers, TA, Koniaris, LG, Furlanetto, RW and Mooney, RA. (2003) Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. Journal of Biological Chemistry, 278, pp. 13740-13746.
32. Shankar, K., Vaidya, VS, Corton, JC, Bucci, TJ, Liu, J., Waalkes, MP and Mehendale, HM. (2003) Activation of PPAR-alpha in streptozotocin-induced diabetes is essential for resistance against acetaminophen toxicity. Faseb Journal, 17, pp. 1748-1750.
33. Szasz, G., Gruber, W. and Brent, E. (1976) Creative kinose in serum: 1. Determination of optimum reaction conditions. Clinical Chemistry, 22, pp. 650-656.
34. Sznaidman, ML, Haffner, CD, Maloney, PR, Fivush, A., Chao, E., Goreham, D., Sierra, ML, LeGrumelec, C., Xu, HE and Montana, VG (2003) Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)-synthesis and biological activity. Bioorganic & Medicinal Chemistry Letters, 13, pp. 1517-1521.
35. Willson, TM, Brown, PJ, Sternbach, DD and Henke, BR. (2000) The PPARs: from orphan receptors to drug discovery. Journal of Medicinal Chemistry, 43, pp. 527-550.
36. Witt, CC, Ono, Y., Puschmann, E., McNabb, M., Wu, Y., Gotthardt, M., Witt, SH, Haak, M., Labeit, D., Gregorio, CC, Sorimachi, H., Granzier, H. and Labeit, S. (2004) Induction and myofibrillar targeting of CARP, and suppression of the Nkx2.5 pathway in the MDM mouse with impaired titin-based signaling. Journal of Molecular Biology, 336, pp. 145-154.